WO2014133416A3 - Замещенная (r)-3-(4-метилкарбамоил-3-фторфениламино)тетрагидрофуран-3-енкарбоновая кислота (варианты) и ее эфир, способ получения и применения - Google Patents

Замещенная (r)-3-(4-метилкарбамоил-3-фторфениламино)тетрагидрофуран-3-енкарбоновая кислота (варианты) и ее эфир, способ получения и применения Download PDF

Info

Publication number
WO2014133416A3
WO2014133416A3 PCT/RU2014/000122 RU2014000122W WO2014133416A3 WO 2014133416 A3 WO2014133416 A3 WO 2014133416A3 RU 2014000122 W RU2014000122 W RU 2014000122W WO 2014133416 A3 WO2014133416 A3 WO 2014133416A3
Authority
WO
WIPO (PCT)
Prior art keywords
fluorophenylamino
methylcarbamoyl
tetrahydrofuran
substituted
producing
Prior art date
Application number
PCT/RU2014/000122
Other languages
English (en)
French (fr)
Other versions
WO2014133416A2 (ru
WO2014133416A8 (ru
Inventor
Александр Васильевич ИВАЩЕНКО
Олег Дмитриевич МИТЬКИН
Дмитрий Владимирович КРАВЧЕНКО
Антон Александрович ВОРОБЬЕВ
Андрей Сергеевич ТРИФИЛЕНКОВ
Original Assignee
Общество с ограниченной ответственностью "Авионко" (ООО "Авионко")
ИВАЩЕНКО, Андрей Александович
САВЧУК, Николай Филиппович
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA2901107A priority Critical patent/CA2901107C/en
Priority to KR1020157026287A priority patent/KR102204267B1/ko
Priority to JP2015560137A priority patent/JP6341939B2/ja
Priority to EP14756865.3A priority patent/EP2963026B1/en
Priority to US14/828,540 priority patent/US20160016925A1/en
Priority to CN201480010767.0A priority patent/CN105008340A/zh
Application filed by Общество с ограниченной ответственностью "Авионко" (ООО "Авионко"), ИВАЩЕНКО, Андрей Александович, САВЧУК, Николай Филиппович filed Critical Общество с ограниченной ответственностью "Авионко" (ООО "Авионко")
Priority to AU2014221468A priority patent/AU2014221468B2/en
Priority to EA201500754A priority patent/EA027369B1/ru
Publication of WO2014133416A2 publication Critical patent/WO2014133416A2/ru
Publication of WO2014133416A3 publication Critical patent/WO2014133416A3/ru
Publication of WO2014133416A8 publication Critical patent/WO2014133416A8/ru
Priority to HK16103440.2A priority patent/HK1215436A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Abstract

Настоящее изобретение относится к новым химическим соединениям общей формулы 1 - полупродуктам синтеза ингибиторов андрогеновых рецепторов, представляющих интерес в качестве противораковых препаратов. Предметом изобретения является также способы получения новых соединений общей формулы 1.1 -ингибиторов андрогеновых рецепторов. Замещенные 3-(4-метилкарбамоил-3-фторфениламино)тетрагидрофуран-3-енкарбоновые кислоты, или эфиры общей формулы 1, 1.1 или их стереоизомеры, формула (1) где R1=C1-C4алкил; R2=H, CH2OCH2CH2Si(CH3)3; формула (1,1) где R1=H, C1-C4алкил; R2=H, CH2OCH2CH2Si(CH3)3.
PCT/RU2014/000122 2013-02-27 2014-02-26 Замещенная (r)-3-(4-метилкарбамоил-3-фторфениламино)тетрагидрофуран-3-енкарбоновая кислота (варианты) и ее эфир, способ получения и применения WO2014133416A2 (ru)

Priority Applications (9)

Application Number Priority Date Filing Date Title
KR1020157026287A KR102204267B1 (ko) 2013-02-27 2014-02-26 대체된 (r)-3-(4-메틸카바모일-3-플루오로페닐아미노)테트라하이드로퓨란-3-엔카르복실산(변이체) 및 이의 에스테르, 제조 방법 및 용도
JP2015560137A JP6341939B2 (ja) 2013-02-27 2014-02-26 置換された（ｒ）−３−（４−メチルカルバモイル−３−フルオロフェニルアミノ）テトラヒドロフラン−３−エンカルボン酸（変種）及びそのエステル、調製のための方法並びに使用
EP14756865.3A EP2963026B1 (en) 2013-02-27 2014-02-26 Substituted (r)-3-(4-methylcarbamoyl-3-fluorophenylamino)tetrahydrofuran-3-enecarboxylic acid (variants) and ester thereof, method for producing and using same
US14/828,540 US20160016925A1 (en) 2013-02-27 2014-02-26 Substituted (R)-3-(4-methylcarbamoyl-3-fluorophenylamino)tetrahydrofuran-3-encarboxylic acid (variants) and ester thereof, method for preparation and use
CN201480010767.0A CN105008340A (zh) 2013-02-27 2014-02-26 取代的(r)-3-(4-甲基氨基甲酰基-3-氟苯基氨基)四氢呋喃-3-甲酸(变体)和其酯，其制备方法和用途
CA2901107A CA2901107C (en) 2013-02-27 2014-02-26 Substituted (r)-3-(4-methylcarbamoyl-3-fluorophenylamino)tetrahydrofuran-3-encarboxylic acid (variants) and ester thereof, method for preparation and use.
AU2014221468A AU2014221468B2 (en) 2013-02-27 2014-02-26 Substituted (R)-3-(4-methylcarbamoyl-3-fluorophenylamino)tetrahydrofuran-3-enecarboxylic acid (variants) and ester thereof, method for producing and using same
EA201500754A EA027369B1 (ru) 2013-02-27 2014-02-26 Замещенная (r)-3-(4-метилкарбамоил-3-фторфениламино)тетрагидрофуран-3-енкарбоновая кислота и ее эфир в качестве полупродуктов для синтеза ингибиторов андрогенных рецепторов
HK16103440.2A HK1215436A1 (zh) 2013-02-27 2016-03-23 取代的 -甲基氨基甲酰基- -氟苯基氨基 四氫呋喃- -甲酸 變體 和其酯，其製備方法和用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2013108672 2013-02-27
RU2013108672/04A RU2520134C1 (ru) 2013-02-27 2013-02-27 Замещенные (r)-3-(4-метилкарбамоил-3-фторфениламино)-тетрагидро-фуран-3-енкарбоновые кислоты и их эфиры, способ их получения и применения

Publications (3)

Publication Number Publication Date
WO2014133416A2 WO2014133416A2 (ru) 2014-09-04
WO2014133416A3 true WO2014133416A3 (ru) 2014-12-18
WO2014133416A8 WO2014133416A8 (ru) 2015-09-11

Family

ID=51216931

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2014/000122 WO2014133416A2 (ru) 2013-02-27 2014-02-26 Замещенная (r)-3-(4-метилкарбамоил-3-фторфениламино)тетрагидрофуран-3-енкарбоновая кислота (варианты) и ее эфир, способ получения и применения

Country Status (11)

Country Link
US (1) US20160016925A1 (ru)
EP (1) EP2963026B1 (ru)
JP (1) JP6341939B2 (ru)
KR (1) KR102204267B1 (ru)
CN (2) CN105008340A (ru)
AU (1) AU2014221468B2 (ru)
CA (1) CA2901107C (ru)
EA (1) EA027369B1 (ru)
HK (1) HK1215436A1 (ru)
RU (1) RU2520134C1 (ru)
WO (1) WO2014133416A2 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2557235C1 (ru) * 2014-07-08 2015-07-20 Александр Васильевич Иващенко Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006124118A1 (en) * 2005-05-13 2006-11-23 The Regents Of The University Of California Diarylhydantoin compounds
WO2007127010A2 (en) * 2006-03-29 2007-11-08 The Regents Of The University Of California Diarylthiohydantoin compounds
RU2434851C1 (ru) * 2010-07-22 2011-11-27 Александр Васильевич Иващенко Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20081834A1 (es) * 2006-12-31 2009-01-16 Boehringer Ingelheim Int Proceso para la sintesis de derivados de acido 3-amino-tetrahidrofuran-3-carboxilico y uso de los mismos como medicamentos
US8461343B2 (en) 2007-03-27 2013-06-11 Sloan-Kettering Institute For Cancer Research Synthesis of thiohydantoins
WO2010118354A1 (en) * 2009-04-09 2010-10-14 Medivation Prostate Therapeutics, Inc. Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods for use thereof
BR112012021406B1 (pt) * 2010-02-24 2021-08-10 Medivation Prostate Therapeutics Llc Processos para a síntese dos compostos de diariltioidantoína e diarilidantoína

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006124118A1 (en) * 2005-05-13 2006-11-23 The Regents Of The University Of California Diarylhydantoin compounds
WO2007127010A2 (en) * 2006-03-29 2007-11-08 The Regents Of The University Of California Diarylthiohydantoin compounds
RU2434851C1 (ru) * 2010-07-22 2011-11-27 Александр Васильевич Иващенко Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения

Also Published As

Publication number Publication date
CN105008340A (zh) 2015-10-28
US20160016925A1 (en) 2016-01-21
JP2016510025A (ja) 2016-04-04
KR20150130327A (ko) 2015-11-23
CN110669027A (zh) 2020-01-10
CN110669027B (zh) 2021-07-06
AU2014221468B2 (en) 2018-05-17
EP2963026A4 (en) 2016-08-03
WO2014133416A2 (ru) 2014-09-04
KR102204267B1 (ko) 2021-01-18
EP2963026A2 (en) 2016-01-06
RU2520134C1 (ru) 2014-06-20
HK1215436A1 (zh) 2016-08-26
EP2963026B1 (en) 2020-04-29
EA027369B1 (ru) 2017-07-31
JP6341939B2 (ja) 2018-06-13
CA2901107C (en) 2020-10-27
EA201500754A1 (ru) 2016-01-29
WO2014133416A8 (ru) 2015-09-11
CA2901107A1 (en) 2014-09-04
AU2014221468A1 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
PH12017502331A1 (en) 1,4-substituted piperidine derivatives
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
WO2013049726A3 (en) Processes for making compounds useful as inhibitors of atr kinase
MX2012013082A (es) Derivados de 2-aminopiridina utiles como iinhibidores de cinasa atr.
IN2015DN01547A (ru)
PH12015501226A1 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing the same
WO2011087316A3 (ko) 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
MX2017016370A (es) Derivados de 4-bencil y 4-benzoil piperidina sustituidos.
EP4001266A3 (en) Process for preparing methoxy methyl pyridine dicarboxylate
SG11201906688VA (en) Novel ester compounds, method for the production thereof and use thereof
WO2012029077A3 (en) Process for preparing fluticasone propionate/furoate
MX2019006920A (es) Derivados de la espiropiperidina.
EA201200820A1 (ru) Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
MX2021011971A (es) Proceso para preparar cicloserinas sustituidas.
TN2014000329A1 (en) Method for preparing compound by novel michael addition reaction using water or various acids as additive
WO2014133416A3 (ru) Замещенная (r)-3-(4-метилкарбамоил-3-фторфениламино)тетрагидрофуран-3-енкарбоновая кислота (варианты) и ее эфир, способ получения и применения
EA201790659A1 (ru) Способ получения сложных эфиров карбоновых кислот в присутствии титансодержащего катализатора
CA2928305C (en) A crystalline anhydrous form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
MX349985B (es) Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi.
WO2012050623A3 (en) Novel phenoxyisobutyric acid compounds and methods for synthesis
WO2017046816A3 (en) Process for the preparation of derivatives of benzodioxole
WO2016038622A3 (en) Improved process for the preparation of [[2(s)-[[4(r)-(3-hydroxyphenyl)-3(r),4-dimethyl-1-piperidinyl]methyl]-1 -oxo-3-phenylpropyl]amino]acetic acid dihydrate
WO2013046233A3 (en) Process for the preparation of octreotide acetate
MX353994B (es) Formas polimorfas.
WO2015002746A3 (en) Biobased epoxidized fatty acid ester plasticizers

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2901107

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 201500754

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 14828540

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2014756865

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2015560137

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20157026287

Country of ref document: KR

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2014221468

Country of ref document: AU

Date of ref document: 20140226

Kind code of ref document: A